tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Neurocrine (NBIX)
NASDAQ:NBIX
US Market
NBIX
Neurocrine
RESEARCH TOOLSreports

Neurocrine (NBIX) Stock News & Sentiment

Compare
1,551 Followers
3 Best Stocks to Buy Today, 1/28/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 1/28/2026, According to Top Analysts
2d ago
IVA
NBIX
Neurocrine Biosciences: Ingrezza-Driven Strength and Risk-Balanced Pipeline Support Buy Rating Despite Valbenazine Setback
Premium
Ratings
Neurocrine Biosciences: Ingrezza-Driven Strength and Risk-Balanced Pipeline Support Buy Rating Despite Valbenazine Setback
1M ago
NBIX
Buy Rating Reaffirmed on Neurocrine: Limited Impact from Trial Setback, Strength in Core Execution and Deep Pipeline Upside
Premium
Ratings
Buy Rating Reaffirmed on Neurocrine: Limited Impact from Trial Setback, Strength in Core Execution and Deep Pipeline Upside
1M ago
NBIX
Neurocrine Biosciences Launches Phase 2 Trial for Bipolar I Disorder Treatment
Premium
Company Announcements
Neurocrine Biosciences Launches Phase 2 Trial for Bipolar I Disorder Treatment
1M ago
NBIX
Neurocrine Biosciences Advances Schizophrenia Treatment with New Phase 2a Clinical Study
Premium
Company Announcements
Neurocrine Biosciences Advances Schizophrenia Treatment with New Phase 2a Clinical Study
1M ago
NBIX
Neurocrine’s Strategic Growth and Innovation: Analyst Upgrades Price Target to $198 with Buy Rating
Premium
Ratings
Neurocrine’s Strategic Growth and Innovation: Analyst Upgrades Price Target to $198 with Buy Rating
1M ago
NBIX
Neurocrine Biosciences: Strong R&D Pipeline and Strategic Advancement in Neuropsychiatry and Obesity Treatment
Premium
Ratings
Neurocrine Biosciences: Strong R&D Pipeline and Strategic Advancement in Neuropsychiatry and Obesity Treatment
1M ago
NBIX
More NBIX News >

NBIX News on the Web

Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Neurocrine (NBIX)
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Concentra Group Holdings Parent, Inc. (CON), Neurocrine (NBIX)
TipRanks News
Bullish
3 Best Stocks to Buy Today, 1/28/2026, According to Top Analysts
TipRanks News
Bullish
Neurocrine (NBIX) Receives a Buy from Piper Sandler
TipRanks News
Bullish
Bank of America Securities Reaffirms Their Buy Rating on Neurocrine (NBIX)
TipRanks News
Bullish
Neurocrine initiates Phase 2 study of NBI-1065890 in adults with TD
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI), Madrigal Pharmaceuticals (MDGL) and Neurocrine (NBIX)
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE) and Neurocrine (NBIX)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
NBIX
Sector Average
Media Buzz
This Week8 articles
Weekly Average5 articles
News Sentiment
This Week100%
Sector Average75%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBIX’s Media Buzz Sentiment?
8 articles about NBIX were published this week. In an average week, 5 articles are published.
    What is NBIX’s weekly average amount of articles?
    In an average week, 5 articles about NBIX are published.
      What is NBIX’s News Sentiment?
      100% of articles about NBIX were positive this week, compared to its sector average of 75%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        KRROKorro Bio
        IMAImageneBio
        Showing the stocks with the most bullish news sentiment over the past week